The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Climate Change Will Raise Water Levels Of Asia’s Rivers
A study shows that all five of Asia's major river systems will be affected by glacier melts caused by climate change.
RIKEN’s K Computer Tops 2014 Supercomputer Rankings
The K computer at RIKEN has come out tops in the 2014 Graph 500 supercomputer ranking, beating Sequoia and Mira from the United States.
Oxidative Damage To Liver Worsens Obesity
Research from Monash University has uncovered the link between diabetes, obesity and fatty liver disease: oxidative stress caused by free radicals.
Sanjaya Rajaram Awarded 2014 World Food Prize
Dr. Sanjaya Rajaram has been awarded the 2014 World Food Prize for his groundbreaking research in wheat breeding that spurred the Green Revolution.
Making Smart Technologies Work For Cities
Experts from academia, industry and government discuss ways to integrate science and technology into building sustainable cities at the World Cities Summit 2014.
Eisai Completes Phase III Trial For Epilepsy Drug
The Phase III clinical trial for Eisai's in-house developed AMPA receptor antagonist Fycompa® has met its primary endpoints in patients with severe seizures.
IHEP Becomes First Asian Member of Physics Literature Database
China's Institute of High Energy Physics (IHEP) is the first Asian member of the INSPIRE high energy physics literature database.
Thinking Out Of The Box For Malaria Research
The open access Malaria Box project by Medicines for Malaria Venture has led to nine peer reviewed papers and unexpected discoveries for diseases other than malaria.
China’s CBMG Begins Trading On NASDAQ
Cellular Biomedicine Group, which develops cell therapeutics targeted at the Chinese market, has listed on NASDAQ.